Literature DB >> 23208786

Genetic deletion of the HIF-1α isoform I.1 in T cells enhances antibacterial immunity and improves survival in a murine peritonitis model.

Peter Georgiev1, Bryan G Belikoff, Stephen Hatfield, Akio Ohta, Michail V Sitkovsky, Dmitriy Lukashev.   

Abstract

Hypoxia-adenosinergic suppression and redirection of the immune response has been implicated in the regulation of antipathogen and antitumor immunity, with hypoxia-inducible factor 1α (HIF-1α) playing a major role. In this study, we investigated the role of isoform I.1, a quantitatively minor alternative isoform of HIF-1α, in antibacterial immunity and sepsis survival. By using the cecal ligation and puncture model of bacterial peritonitis, we studied the function of I.1 isoform in T cells using mice with total I.1 isoform deficiency and mice with T-cell-targeted I.1 knockdown. We found that genetic deletion of the I.1 isoform resulted in enhanced resistance to septic lethality, significantly reduced bacterial load in peripheral blood, increased M1 macrophage polarization, augmented levels of proinflammatory cytokines in serum, and significantly decreased levels of the anti-inflammatory cytokine IL-10. Our data suggest a previously unrecognized immunosuppressive role for the I.1 isoform in T cells during bacterial sepsis. We interpret these data as indicative that the activation-inducible isoform I.1 hinders the contribution of T cells to the antibacterial response by affecting M1/M2 macrophage polarization and microbicidal function.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23208786      PMCID: PMC3757952          DOI: 10.1002/eji.201242765

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  54 in total

1.  A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival.

Authors:  P P Lee; D R Fitzpatrick; C Beard; H K Jessup; S Lehar; K W Makar; M Pérez-Melgosa; M T Sweetser; M S Schlissel; S Nguyen; S R Cherry; J H Tsai; S M Tucker; W M Weaver; A Kelso; R Jaenisch; C B Wilson
Journal:  Immunity       Date:  2001-11       Impact factor: 31.745

2.  HIF-1alpha is essential for myeloid cell-mediated inflammation.

Authors:  Thorsten Cramer; Yuji Yamanishi; Björn E Clausen; Irmgard Förster; Rafal Pawlinski; Nigel Mackman; Volker H Haase; Rudolf Jaenisch; Maripat Corr; Victor Nizet; Gary S Firestein; Hans Peter Gerber; Napoleone Ferrara; Randall S Johnson
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

Review 3.  The pathophysiology and treatment of sepsis.

Authors:  Richard S Hotchkiss; Irene E Karl
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

4.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

5.  Ecto-5'-nucleotidase (CD73) decreases mortality and organ injury in sepsis.

Authors:  György Haskó; Balázs Csóka; Balázs Koscsó; Rachna Chandra; Pál Pacher; Linda F Thompson; Edwin A Deitch; Zoltán Spolarics; László Virág; Pál Gergely; Rolando H Rolandelli; Zoltán H Németh
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

6.  Selective defects of T lymphocyte function in patients with lethal intraabdominal infection.

Authors:  C D Heidecke; T Hensler; H Weighardt; N Zantl; H Wagner; J R Siewert; B Holzmann
Journal:  Am J Surg       Date:  1999-10       Impact factor: 2.565

7.  Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality.

Authors:  D G Remick; D R Call; S J Ebong; D E Newcomb; P Nybom; J A Nemzek; G E Bolgos
Journal:  Crit Care Med       Date:  2001-03       Impact factor: 7.598

8.  IL-10 is critical for host resistance and survival during gastrointestinal helminth infection.

Authors:  Lisa R Schopf; Karl F Hoffmann; Allen W Cheever; Joseph F Urban; Thomas A Wynn
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

9.  Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.

Authors:  A Giatromanolaki; E Sivridis; E Maltezos; D Papazoglou; C Simopoulos; K C Gatter; A L Harris; M I Koukourakis
Journal:  J Clin Pathol       Date:  2003-03       Impact factor: 3.411

10.  Differential regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1 alpha in activated T lymphocytes.

Authors:  D Lukashev; C Caldwell; A Ohta; P Chen; M Sitkovsky
Journal:  J Biol Chem       Date:  2001-10-15       Impact factor: 5.157

View more
  10 in total

Review 1.  Structural Analysis of Mitochondrial Dynamics-From Cardiomyocytes to Osteoblasts: A Critical Review.

Authors:  Daniel H Mendelsohn; Katja Schnabel; Andreas Mamilos; Samuel Sossalla; Steffen Pabel; Georg Daniel Duerr; Karsten Keller; Volker H Schmitt; Friedrich Barsch; Nike Walter; Ronald Man Yeung Wong; Thaqif El Khassawna; Tanja Niedermair; Volker Alt; Markus Rupp; Christoph Brochhausen
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

Review 2.  Integrating canonical and metabolic signalling programmes in the regulation of T cell responses.

Authors:  Kristen N Pollizzi; Jonathan D Powell
Journal:  Nat Rev Immunol       Date:  2014-07       Impact factor: 53.106

Review 3.  Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapy.

Authors:  Stephen M Hatfield; Michail V Sitkovsky
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

Review 4.  Hypoxia-Inducible Factor (HIF) as a Pharmacological Target for Prevention and Treatment of Infectious Diseases.

Authors:  Tamara Bhandari; Victor Nizet
Journal:  Infect Dis Ther       Date:  2014-06-24

5.  Protectin DX increases survival in a mouse model of sepsis by ameliorating inflammation and modulating macrophage phenotype.

Authors:  Haifa Xia; Lin Chen; Hong Liu; Zhipeng Sun; Wen Yang; Yiyi Yang; Shunan Cui; Shengnan Li; Yaxin Wang; Limin Song; Amro Fayez Abdelgawad; You Shang; Shanglong Yao
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

6.  Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells.

Authors:  Romain Vuillefroy de Silly; Laura Ducimetière; Céline Yacoub Maroun; Pierre-Yves Dietrich; Madiha Derouazi; Paul R Walker
Journal:  Eur J Immunol       Date:  2015-05-26       Impact factor: 5.532

Review 7.  Hypoxia/HIF Modulates Immune Responses.

Authors:  Yuling Chen; Timo Gaber
Journal:  Biomedicines       Date:  2021-03-05

8.  Effect of Hypoxia on the Pathogenesis of Acinetobacter baumannii and Pseudomonas aeruginosa In Vitro and in Murine Experimental Models of Infection.

Authors:  María Luisa Gil-Marqués; María Eugenía Pachón-Ibáñez; Jerónimo Pachón; Younes Smani
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

Review 9.  The Ups and Downs of Metabolism during the Lifespan of a T Cell.

Authors:  Renu Balyan; Namrata Gautam; Nicholas R J Gascoigne
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

10.  Quantitative Analyses Reveal How Hypoxia Reconfigures the Proteome of Primary Cytotoxic T Lymphocytes.

Authors:  Sarah H Ross; Christina M Rollings; Doreen A Cantrell
Journal:  Front Immunol       Date:  2021-09-17       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.